<p>Lane 0, negative control without template; lanes 1, 2, 3, 4, amplicon fragments by compound specific primer pair Lec-118-F/R at the concentration of 500 nmol L<sup>−1</sup>, 50 nmol L<sup>−1</sup>, 25 nmol L<sup>−1</sup>, 5 nmol L<sup>−1</sup> respectively; lanes 5, 6, 7, 8, amplicon fragments by UP (500 nmol L<sup>−1</sup>) and compound specific primer Lec-118-F/R at a series concentrations of 500 nmol L<sup>−1</sup>, 50 nmol L<sup>−1</sup>, 25 nmol L<sup>−1</sup>,5 nmol L<sup>−1</sup>; lane M, 100 bp DNA Marker.</p
<p>A) Known concentrations of <i>Tbx21 (T), Gata3 (G), Rorγt (R), Foxp3 (F), Bcl-6 (B6)</i>, and <i>...
Background: Robust designs of PCR-based molecular diagnostic assays rely on the discrimination po...
The rate of amplification of abundant PCR products generally declines faster than that of less abund...
<p>(<b>A</b>) Comparison of specificity between specific primers and compound specific primers. Lane...
The success of PCR is partly based on its exponential amplifica-tion characteristics. Nevertheless, ...
<p>Lanes 1–10, 9-fold dilutions of human genomic DNA; Lane 11, negative control. MW, Molecular Weigh...
Lanes 1: DNA marker, lanes 2: no template control, lanes 3–8: ratios of external vs. inner primer (1...
<p>Lane A, B, C, D, E, amplicon fragments by UP (500 nmol L<sup>−1</sup>) and compound specific prim...
<p>Panel <b>A</b> shows plateau values in response to changes in primer concentration (<i>Glycine ma...
<p>Lanes 1 to 8 show amplicon results for <i>L</i>. <i>monocytogenes</i> (from 2.3 × 10<sup>8</sup> ...
<p>(A) PCR verification of expected 199 bp target length amplicon. Lane M, 50 bp DNA ladder (Molecul...
<p>Endpoint PCR performed with individual primer set using 10-fold serially diluted multi target art...
<p>(A) Principle of the single-nucleotide primer extension method illustrated through analysis of a ...
<p>Left, The RFU ratios (sample/control) increased in proportion to the concentration of p-IS<i>6110...
<p>Emulsion PCR amplification was carried out for 35 cycles; the number of templates was 0.01 pmol/m...
<p>A) Known concentrations of <i>Tbx21 (T), Gata3 (G), Rorγt (R), Foxp3 (F), Bcl-6 (B6)</i>, and <i>...
Background: Robust designs of PCR-based molecular diagnostic assays rely on the discrimination po...
The rate of amplification of abundant PCR products generally declines faster than that of less abund...
<p>(<b>A</b>) Comparison of specificity between specific primers and compound specific primers. Lane...
The success of PCR is partly based on its exponential amplifica-tion characteristics. Nevertheless, ...
<p>Lanes 1–10, 9-fold dilutions of human genomic DNA; Lane 11, negative control. MW, Molecular Weigh...
Lanes 1: DNA marker, lanes 2: no template control, lanes 3–8: ratios of external vs. inner primer (1...
<p>Lane A, B, C, D, E, amplicon fragments by UP (500 nmol L<sup>−1</sup>) and compound specific prim...
<p>Panel <b>A</b> shows plateau values in response to changes in primer concentration (<i>Glycine ma...
<p>Lanes 1 to 8 show amplicon results for <i>L</i>. <i>monocytogenes</i> (from 2.3 × 10<sup>8</sup> ...
<p>(A) PCR verification of expected 199 bp target length amplicon. Lane M, 50 bp DNA ladder (Molecul...
<p>Endpoint PCR performed with individual primer set using 10-fold serially diluted multi target art...
<p>(A) Principle of the single-nucleotide primer extension method illustrated through analysis of a ...
<p>Left, The RFU ratios (sample/control) increased in proportion to the concentration of p-IS<i>6110...
<p>Emulsion PCR amplification was carried out for 35 cycles; the number of templates was 0.01 pmol/m...
<p>A) Known concentrations of <i>Tbx21 (T), Gata3 (G), Rorγt (R), Foxp3 (F), Bcl-6 (B6)</i>, and <i>...
Background: Robust designs of PCR-based molecular diagnostic assays rely on the discrimination po...
The rate of amplification of abundant PCR products generally declines faster than that of less abund...